Genetic screen

A genetic screen (often shortened to screen) is a procedure or test to identify and select individuals who possess a phenotype of interest. A genetic screen for new genes is often referred to as forward genetics as opposed to reverse genetics, the term for identifying mutant alleles in genes that are already known. Mutant alleles that are not tagged for rapid cloning are mapped and cloned by positional cloning.

Creating a mutant population
Since unusual alleles and phenotypes are rare, geneticists expose the individuals that are to be screened to a mutagen, such as a chemical or radiation, which generates mutations in their chromosomes. The use of mutagens enables "saturation screens" one of the first of which was performed by Nobel laureates Christiane Nüsslein-Volhard and Eric Wieschaus. A saturation screen is performed to uncover every gene that is involved in a particular phenotype in a given species. This is done by screening and mapping genes until no new genes are found. Mutagens such as random DNA insertions by transformation or active transposons can also be used to generate new mutants. These techniques have the advantage of tagging the new alleles with a known molecular (DNA) marker that can facilitate the rapid identification of the gene.

Types of screen
A basic screen involves looking for a phenotype of interest in the mutated population. One might screen for obvious phenotypes such as fruit flies with no wings or an Arabidopsis flower with no petals.

More subtle is a temperature sensitive screen that involves temperature shifts to enhance the mutant phenotype. A population grown at low temperature would have a normal phenotype, however, the mutation in the particular gene would make it unstable at a higher temperature. A screen for temperature sensitivity in fruit flies, for example, might involve raising the temperature in the cage until some flies faint, then opening a portal to let the others escape. Individuals selected in a screen are liable to carry an unusual version of a gene involved in the phenotype of interest. An advantage of alleles found in this type of screen is that the mutant phenotype is conditional and can be activated by simply raising the temperature. A null mutation in such a gene may be embryo lethal and such mutants would be missed in a basic screen.

An enhancer/suppressor screen is the most sophisticated type of genetic screen. In this case a mutagenised population has an allele of a gene that leads to a weak mutant phenotype in the biological process of interest. For example, with regard to fruit fly wing development, a weak allele may have small abnormal wings whereas a strong/null allele would have no wings. In this sensitised background it is possible to discover new mutants that either enhance the phenotype (small wings to no wings) or suppress the phenotype (small wings to normal wings). Such a screen has two advantages. First, new genes identified in the screen are often involved in the same biological process as the weak allele in the genetic background, in this case wing formation. Second, due to genetic redundancy, the mutant genes discovered may not have a visible phenotype of their own. In a more basic screen these would not be discovered, however, in the sensitised genetic background a visible phenotype is clear.

Mapping mutants
By the classical genetics approach, a researcher would then locate (map) the gene on its chromosome by crossbreeding with individuals that carry other unusual traits and collecting statistics on how frequently the twohave used phenotypic traits to map the new mutant alleles. With the advent of genomic sequences for model systems such as Drosophila, Arabidopsis and C. elegans many SNPs have now been identified that can be used as traits for mapping. SNPs are the preferred traits for mapping since they are very frequent, on the order of one difference per 1000 base pairs, between different varieties of organism.

Positional cloning
Positional cloning typically involves the isolation of partially overlapping DNA segments from genomic libraries in an attempt to progress along the chromosome toward a disease gene. During the course of positional cloning, one needs to determine whether the DNA segment currently under consideration is part of a disease gene. Tests used for this purpose include cross-species hybridization, identification of unmethylated CpG islands, exon trapping, direct cDNA selection, computer analysis of DNA sequence, mutation screening in affected individuals, and tests of gene expression. For many genomes SNPs are not known and therefore positional cloning is required to identify polymorphisms that flank the mapped allele. This process requires that DNA fragments from the closest known genetic marker are progressively cloned getting closer to the mutant allele with each new clone. This process produces a contig map of the locus and is known as chromosome walking.

For each new DNA clone a polymorphism is identified and tested in the mapping population for its recombination frequency compared to the mutant phenotype. When the DNA clone is at or close to the mutant allele the recombination frequency should be equal to zero. If the chromosome walk proceeds through the mutant allele the new polymorphisms will start to show increase in recombination frequency compared to the mutant phenotype. Depending on the size of the mapping population, and luck, the mutant allele can be narrowed down to a small region (<30 Kb). Sequence comparison between wild type and mutant DNA in that region is then required to locate the DNA mutation that causes the phenotypic difference.